Modern science, perhaps more than any other sphere, benefits from open, interconnected networks of knowledge and of people. We continue to pool larger subject samples, to share more data, and to seek the expertise of specialists across a veritable pick 'n' mix of labs.
Until recently, almost 95% of the human genome was neglected by medical research.(1) Despite completing the full genome map in 2003, researchers were sure that only the coding genes – that active 5% – played any role in disease. The full gene sequencing that once took 13 years can now be done in a day, however, and it is only with this leap in technology that the enigmatic 95% has come in to focus.
For those in search of employment, the job application process can become second nature. Certainly, according to a recent article by Indeed (1), applicants are focusing less on dedicated 'job seeking' time, and more on a constant readiness to apply throughout the day, as new opportunities arise.
Since the introduction of the first therapeutic monoclonal antibody product in the 1980’s, antibodies are now dominating the biopharmaceutical market and are the fastest growing class of therapeutics.
Recent reports have shown the UK recruitment industry has acquired more agencies than in the US. In a report by Ciett 2014 Economic Report it shows there are around 18,000 agencies in the UK compared to 17,000 in the states.
Moving into 2015, the HEOR and Market Access industry is looking to be one of movement with plenty of new opportunities arising from a talent acquisition point of view.
My name is Jessica and I’m the medical writing specialist here at Paramount Recruitment. I have over four years’ experience working with a range of medical and healthcare communication agencies across the UK, Europe and most recently internationally.
I have been working at Paramount Recruitment as the Operations Manager for almost 18 months, after previously spending almost 20 years within an outsourced contact centre.
Here at Paramount Recruitment we recently launched a survey asking our candidates what they think about the service we offer. We sent the survey to the candidates who have been submitted for a job in the past 12 months with a personal email from Talent Director and Co-founder Eugene McDaid…
Here at Paramount Recruitment, we recently launched a survey asking clients what their top 10 pet hates are when dealing with recruiters. Although we expected to see some of the answers, many of the pet hates were a bit of a shock to see…
It’s a very exciting time in the recruitment market – The REC are forecasting that the UK recruitment market will see accelerating growth with the first quarter growing at about 7% followed by the market picking up to above 8% across the latter part of 2014…
So it is an exciting time in the market place the REC anticipates 2014 being a year full of opportunity for the UK recruitment industry.
The debate over creating a centralized European medical device approval agency is still going strong. In large part, fueled by reactions to the PiP breast implant tragedy, many legislative groups are calling for a centralized standard throughout Europe controlled by one agency.
An agreement has been reached where Pfizer will be paying $491m (£320m) to settle a probe into illegal marketing of the drug, Rapamune by Wyeth, a company that was procured by Pfizer in 2009.